|
|
| Research article summary (published 29 Nov 2002): |
Health economics, economic evaluation, and glaucoma.
Full Abstract
Glaucoma has not received a great deal of attention from health economists in the past, partly due to the fact that no new treatments have been introduced for some time. Economic evaluation is generally performed for new technologies, to assess their cost-effectiveness compared with current treatments, to estimate the potential changes in the use of health care resources that their introduction may produce, and to make decisions about their reimbursement status and formulary inclusion. Economic studies in glaucoma have been largely limited to studies about cost, because a useful outcome measure has been lacking. Therapy aims at reducing intraocular pressure, but the data to estimate the absolute risk of vision loss due to high pressure have been lacking. Hence, it has been impossible to assess the benefit of treatments in terms of their ability to reduce blindness. However, as new out knowledge about these issues increases and more data become available, such studies become possible. This review illustrates the issues encountered when performing economic evaluation in glaucoma and reviews the current economic literature in the field.
Author information
Author/s: Kobelt, Gisela (G);
Affiliation: kobelt.gisele(-atsign-)wanadoo.fr
Journal and publication information
Publication Type: Journal Article; Review
Journal: Journal of glaucoma (J Glaucoma), published in United States. (Language: eng)
Reference: 2002-Dec; vol 11 (issue 6) : pp 531-9
Dates: Created 2002/12/16; Completed 2003/03/10; Revised 2006/11/03;
PMID: 12483101, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Related articles
These are the most related articles currently in our database:
- Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands.
30 May 2001 - Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.
29 Sep 2005 - Considerations in developing model-based economic evaluations of glaucoma treatment.
29 Nov 2006 - Trends in cost of major eye diseases to Medicare, 1991 to 2000.
5 Sep 2006 - The economic burden of glaucoma in the UK. The need for a far-sighted policy.
30 May 1995 - Economic aspects of the management of ocular hypertension.
30 Oct 1980 - A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy.
30 Oct 2005 - Target pressure in glaucoma therapy.
30 Mar 1997 - Blindness prevention through control of ocular hypertension: an epidemiological assessment.
29 Nov 1980
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.